Intensity Therapeutics (INTS) Stock Price & Financial Analysis
Intensity Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Intensity Therapeutics
What is the current stock price for INTS?
As of the latest trading session, INTS stock trades at $4.08. The 52-week range is $0.19–$15.00, with a day range of $4.01–$4.12.
What is the P/E ratio for INTS?
The P/E ratio (Price-to-Earnings) for INTS is shown in the Key Statistics section. This valuation metric helps compare Intensity Therapeutics, Inc. to industry peers.
Does INTS pay dividends?
Intensity Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for INTS?
Analyst ratings and recommendations for INTS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of INTS?
Intensity Therapeutics's market capitalization is $103.4M, classifying it as a micro-cap company. Intensity Therapeutics operates in the Healthcare sector within the Biotechnology industry.